UnitedHealth Group reported strong second-quarter results, with revenues up 12% and adjusted earnings increasing by 28%. The company raised its full-year earnings guidance, increased dividends by 20%, and highlighted strong growth across all segments, driven by innovation and expansion efforts. Positive management commentary and expectations of more tailwinds than headwinds suggest the stock is likely to rally in the short term.

[2]